Mednax, Inc. (MD): Price and Financial Metrics

Mednax, Inc. (MD): $18.43

-0.12 (-0.65%)

POWR Rating

Component Grades













MD POWR Grades

  • Growth is the dimension where MD ranks best; there it ranks ahead of 99.78% of US stocks.
  • The strongest trend for MD is in Growth, which has been heading up over the past 179 days.
  • MD ranks lowest in Sentiment; there it ranks in the 35th percentile.

MD Stock Summary

  • With a year-over-year growth in debt of -40.94%, Mednax Inc's debt growth rate surpasses only 9.99% of about US stocks.
  • Over the past twelve months, MD has reported earnings growth of -133.91%, putting it ahead of merely 14.03% of US stocks in our set.
  • Mednax Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 36.25%, greater than the shareholder yield of 95.42% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Mednax Inc are PLOW, SP, CRS, VVPR, and WGO.
  • MD's SEC filings can be seen here. And to visit Mednax Inc's official web site, go to

MD Valuation Summary

  • MD's price/sales ratio is 1.5; this is 86.78% lower than that of the median Healthcare stock.
  • MD's price/sales ratio has moved down 1.8 over the prior 243 months.
  • MD's price/sales ratio has moved down 1.8 over the prior 243 months.

Below are key valuation metrics over time for MD.

Stock Date P/S P/B P/E EV/EBIT
MD 2021-08-31 1.5 3.4 -52.6 68.0
MD 2021-08-30 1.7 3.8 -57.6 73.1
MD 2021-08-27 1.7 3.7 -56.6 72.1
MD 2021-08-26 1.6 3.5 -54.4 69.9
MD 2021-08-25 1.6 3.6 -55.0 70.5
MD 2021-08-24 1.6 3.6 -54.7 70.2

MD Growth Metrics

    Its 2 year revenue growth rate is now at -0.46%.
  • Its 3 year cash and equivalents growth rate is now at -16.25%.
  • Its 4 year net income to common stockholders growth rate is now at -479.58%.
MD's revenue has moved down $982,034,000 over the prior 70 months.

The table below shows MD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,911.191 76.737 130.964
2021-09-30 1,829.291 20.635 19.152
2021-06-30 1,796.977 129.468 -52.687
2021-03-31 1,833.221 268.863 -760.134
2020-12-31 1,733.951 204.62 -796.488
2020-09-30 2,721.131 344.107 -722.861

MD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MD has a Quality Grade of C, ranking ahead of 56.08% of graded US stocks.
  • MD's asset turnover comes in at 0.609 -- ranking 45th of 81 Healthcare stocks.
  • ENZ, TDOC, and LFMD are the stocks whose asset turnover ratios are most correlated with MD.

The table below shows MD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.609 0.263 0.026
2021-03-31 0.580 0.262 -0.296
2020-12-31 0.479 0.259 -0.262
2020-09-30 0.712 0.243 -0.226
2020-06-30 0.780 0.242 -0.745
2020-03-31 0.763 0.244 -0.454

MD Price Target

For more insight on analysts targets of MD, see our MD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $30.60 Average Broker Recommendation 2 (Hold)

MD Stock Price Chart Interactive Chart >

Price chart for MD

MD Price/Volume Stats

Current price $18.43 52-week high $35.67
Prev. close $18.55 52-week low $17.17
Day low $18.10 Volume 975,000
Day high $18.84 Avg. volume 539,121
50-day MA $21.85 Dividend yield N/A
200-day MA $25.97 Market Cap 1.61B

Mednax, Inc. (MD) Company Bio

MEDNAX Inc. provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company was founded in 1979 and is based in Sunrise, Florida.

MD Latest News Stream

Event/Time News Detail
Loading, please wait...

MD Latest Social Stream

Loading social stream, please wait...

View Full MD Social Stream

Latest MD News From Around the Web

Below are the latest news stories about Mednax Inc that investors may wish to consider to help them evaluate MD as an investment opportunity.

Pediatrix® to Host Premier Neonatology Meetings March 1-6

FORT LAUDERDALE, Fla., February 24, 2022--Mednax and its Pediatrix-affiliated practices will host two premier meetings in neonatal medicine March 1-6 in San Diego.

Yahoo | February 24, 2022

Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference

FORT LAUDERDALE, Fla., February 23, 2022--Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference

Yahoo | February 23, 2022

Mednax's (MD) Q4 Earnings Surpass Estimates, Increase Y/Y

Mednax's (MD) Q4 results improve on better revenues and expanded patient volumes.

Yahoo | February 18, 2022

MEDNAX, Inc. (MD) CEO Mark Ordan on Q4 2021 Results - Earnings Call Transcript

MEDNAX, Inc. (MD) Q4 2021 Earnings Conference Call February 17, 2022, 9:00 AM ET Company Participants Mark Ordan – Chief Executive Officer Marc Richards – Chief Financial Officer Jim Swift – Chief Development Officer Charles Lynch – Senior Vice President, Finance & Strategy Dr. Roger Mack Hinson – Head of...

SA Transcripts on Seeking Alpha | February 17, 2022

Carlyle Group expands its board as a longtime member steps down

The Carlyle Group (NASDAQ: CG) is bringing on two new independent board members while a longtime director retires — moves that will expand the company's board size and tip the scales so that a majority of members will be independent. Linda Hefner Filler and Mark Ordan will join the board of the D.C. private equity giant, effective April 1. Filler is the former president of retail products, chief marketing officer and chief merchandising officer at Walgreen Co. She retired from that position in 2017 and now serves on the boards for D.C.’s Danaher Corp. and Palo Alto, California’s Eversight Inc. Ordan is currently CEO at Mednax Inc. (NYSE: MD), a national medical group based in Sunrise, Florida.

Yahoo | February 17, 2022

Read More 'MD' Stories Here

MD Price Returns

1-mo -24.22%
3-mo -21.17%
6-mo -28.62%
1-year -41.92%
3-year -31.41%
5-year -66.31%
YTD -32.27%
2021 10.88%
2020 -11.69%
2019 -15.79%
2018 -38.25%
2017 -19.83%

Continue Researching MD

Here are a few links from around the web to help you further your research on Mednax Inc's stock as an investment opportunity:

Mednax Inc (MD) Stock Price | Nasdaq
Mednax Inc (MD) Stock Quote, History and News - Yahoo Finance
Mednax Inc (MD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.689 seconds.